An online survey of frontline prescribers found mostly positive attitudes toward antimicrobial stewardship programs (ASPs) but also identified several specific deficiencies related to knowledge, prescribing practices, and awareness of available resources, according to a study yesterday in Infection Control and Hospital Epidemiology.
According to an updated situation report from the Nigeria Centre for Disease Control (NCDC), there are now 61 monkeypox cases in that country, 5 more than last month. This is Africa's largest-ever monkeypox outbreak.
The number of confirmed, probable, and suspected cases in Madagascar's plague outbreak has climbed to 849, 67 of them fatal, the World Health Organization (WHO) said yesterday in an update. The totals reflect increases of 165 cases and 10 deaths since the WHO's last report on Oct 12.
Seattle researchers report that, among men who have sex with men (MSM) in Seattle and King County, Washington, 5% have gonorrhea with reduced susceptibility to azithromycin, according to a study today in Clinical Infectious Diseases.
The CDC issued a foreboding warning, noting that all progress made toward STD elimination in the United States has lost traction.
Although overuse of antimicrobials is a known contributor to antimicrobial resistance in general, researchers reported yesterday they could find no association between numbers of US antimicrobial prescriptions during a recent 8-year period and resistance in the bacteria that causes gonorrhea.
A study today involving 111 patients found that early fecal microbiota transplantation (FMT) dramatically improves survival in severe Clostridium difficile infections (CDIs).
New early-stage research out of the United Kingdom has identified a potential antibiotic candidate for treatment of drug-resistant gonorrhea.
Sequoia Sciences announced yesterday that it has received fast-track designation from the US Food and Drug Administration (FDA) for its investigational vaccine designed to treat recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) bacteria. Fast-track designation expedites the development and review of the vaccine through the US regulatory process.
A study today in Genome Biology suggests methicillin-resistant Staphylococcus aureus (MRSA) emerged several years before methicillin was used to treat S aureus infections.